Hypercholesterolemia Treatment Market Size, Share, and Trends
globenewswire.com
science
2022-10-21 13:00:00

New York, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The global hypercholesterolemia treatment market is anticipated to grow from a value of US$ 27 Bn in 2022 to US$ 34 Bn by the end of 2032, progressing at a CAGR of 2.3% through 2032. Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. The presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases.
